Anti-ATM antibody [EPR20100] - ChIP Grade
- RabMAb
- Recombinant
- KO Validated
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(14 Publications)
Rabbit Recombinant Monoclonal ATM antibody. Suitable for IP, ChIP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human, Mouse, Rat samples. Cited in 14 publications.
View Alternative Names
Serine-protein kinase ATM, Ataxia telangiectasia mutated, A-T mutated, ATM
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-ATM antibody [EPR20100] - ChIP Grade (AB201022)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized SH-SY5Y (Human neuroblastoma cell line from bone marrow) cells labeling ATM with ab201022 at 1/500 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing nuclear and weak cytoplasmic staining on SH-SY5Y cell line.
The nuclear counter stain is DAPI (blue). Tubulin is detected with ab195889 (Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594)) at 1/200 dilution (red).
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) at 1/1000 dilution.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-ATM antibody [EPR20100] - ChIP Grade (AB201022)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed HEK-293 (Human epithelial cell line from embryonic kidney) cells labeling ATM with ab201022 at 1/800 dilution (red) compared with a rabbit monoclonal IgG isotype control (ab172730; black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti rabbit IgG (Alexa Fluorr® 488) at 1/2000 dilution was used as the secondary antibody.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-ATM antibody [EPR20100] - ChIP Grade (AB201022)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa (Human epithelial cell line from cervix adenocarcinoma) cells labeling ATM with ab201022 at 1/500 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing nuclear and weak cytoplasmic staining on HeLa cell line.
The nuclear counter stain is DAPI (blue). Tubulin is detected with ab195889 (Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594)) at 1/200 dilution (red).
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) at 1/1000 dilution.
- ChIP
Supplier Data
ChIP - Anti-ATM antibody [EPR20100] - ChIP Grade (AB201022)
Chromatin was prepared from HCT 116 (Human colorectal carcinoma cell line) cells treated with 1mM Hydroxyurea for 16h and non-treated according to the Abcam X-ChIP protocol. Cells were fixed with formaldehyde for 10 minutes. The ChIP was performed with 25μg of chromatin, 2μg of ab201022 (blue), and 20μl of Anti rabbit IgG sepharose beads. 2μg of rabbit normal IgG was added to the beads control (yellow). The immunoprecipitated DNA was quantified by real time PCR (Sybr green approach).
- IP
Supplier Data
Immunoprecipitation - Anti-ATM antibody [EPR20100] - ChIP Grade (AB201022)
ATM was immunoprecipitated from 0.35 mg of HEK-293 (Human epithelial cell line from embryonic kidney) whole cell lysate with ab201022 at 1/40 dilution. Western blot was performed from the immunoprecipitate using ab201022 at 1/1000 dilution. VeriBlot for IP Detection Reaction (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : HEK-293 whole cell lysate, 10 μg (Input).
Lane 2 : ab201022 IP in HEK-293 whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab201022 in HEK-293 whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 minutes.
ATM cleavage has been documented previously and the fragment pattern is consistent with what has been described in the literature PMID : 16849690
All lanes:
Immunoprecipitation - Anti-ATM antibody [EPR20100] - ChIP Grade (ab201022)
Predicted band size: 351 kDa
Observed band size: 350 kDa
false
- WB
Supplier Data
Western blot - Anti-ATM antibody [EPR20100] - ChIP Grade (AB201022)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-ATM antibody [EPR20100] - ChIP Grade (ab201022) at 1/5000 dilution
All lanes:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 351 kDa
Observed band size: 351 kDa
false
Exposure time: 10s
- WB
Lab
Western blot - Anti-ATM antibody [EPR20100] - ChIP Grade (AB201022)
False colour image of Western blot : Anti-ATM antibody [EPR20100] - ChIP Grade staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab201022 was shown to bind specifically to ATM. A band was observed at 350 kDa in wild-type A549 cell lysates with no signal observed at this size in ATM knockout cell line ab276095 (knockout cell lysate ab283834). To generate this image, wild-type and ATM knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-ATM antibody [EPR20100] - ChIP Grade (ab201022) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
ATM knockout A549 cell lysate at 20 µg
Lane 2:
Western blot - Human ATM knockout A549 cell line (<a href='/en-us/products/cell-lines/human-atm-knockout-a549-cell-line-ab276095'>ab276095</a>)
Lane 3:
HEK-293 cell lysate at 20 µg
Lane 4:
U-2 OS cell lysate at 20 µg
Predicted band size: 351 kDa
Observed band size: 350 kDa
false
- WB
Lab
Western blot - Anti-ATM antibody [EPR20100] - ChIP Grade (AB201022)
Anti-ATM antibody [EPR20100] (ab201022) staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab201022 was shown to bind specifically to ATM. A band was observed at 350 kDa in wild-type MCF7 cell lysates with a reduction in signal observed at this size in ATM heterozygous knockout cell line ab282630. To generate this image, wild-type and ATM heterozygous knockout MCF7 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween$®$ 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
All lanes:
Western blot - Anti-ATM antibody [EPR20100] - ChIP Grade (ab201022) at 1/1000 dilution
Lane 1:
Wild-type MCF7 cell lysate at 20 µg
Lane 2:
ATM knockout MCF7 cell lysate at 20 µg
Lane 2:
Western blot - Human ATM heterozygous knockout MCF7 cell line (<a href='/en-us/products/cell-lines/human-atm-heterozygous-knockout-mcf7-cell-line-ab282630'>ab282630</a>)
Lane 3:
Wild-type A549 cell lysate at 20 µg
Lane 4:
ATM knockout A549 ab283811 cell lysate at 20 µg
Predicted band size: 351 kDa
Observed band size: 350 kDa
false
- WB
Supplier Data
Western blot - Anti-ATM antibody [EPR20100] - ChIP Grade (AB201022)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : Lane 1 and 2 : 3 minutes; Lane 3 : 30 seconds; Lane 4 : 5 seconds; Lane 5 : 1 second
All lanes:
Western blot - Anti-ATM antibody [EPR20100] - ChIP Grade (ab201022) at 1/1000 dilution
Lane 1:
Human testis lysate at 10 µg
Lane 2:
PC-12 (Rat adrenal gland pheochromocytoma cell line) whole cell lysate at 10 µg
Lane 3:
RAW 264.7 (Mouse macrophage cell line transformed with Abelson murine leukemia virus) whole cell lysate at 10 µg
Lane 4:
293 (Human epithelial cell line from embryonic kidney) whole cell lysate at 10 µg
Lane 5:
SH-SY5Y (Human neuroblastoma cell line from bone marrow) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 351 kDa
Observed band size: 351 kDa
false
- WB
Supplier Data
Western blot - Anti-ATM antibody [EPR20100] - ChIP Grade (AB201022)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The identity of the lower MW band at approximately 190 kDa is unknown.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
In Western blot, Anti-ATM antibody [EPR20100] - (ab201022) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-ATM (phospho S1987) antibody [EPR28058-71] (<a href='/en-us/products/primary-antibodies/atm-phospho-s1987-antibody-epr28058-71-ab315019'>ab315019</a>) at 1/1000 dilution
Lane 1:
Untreated NIH/3T3 (mouse embryonic fibroblast) whole cell lysate (untreated membrane) at 20 µg
Lane 2:
NIH/3T3 treated with UV-C for 100J/cm2, then recovery 2 hours, whole cell lysate (untreated membrane) at 20 µg
Lane 3:
NIH/3T3 treated with UV-C for 100J/cm2, then recovery 2 hours, whole cell lysate (phosphatase treated membrane) at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 349 kDa,124 kDa
false
Exposure time: 81s
- WB
Supplier Data
Western blot - Anti-ATM antibody [EPR20100] - ChIP Grade (AB201022)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The identity of the lower MW band at approximately 190 kDa is unknown.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
In Western blot, Anti-ATM antibody [EPR20100] - (ab201022) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-ATM (phospho S1987) antibody [EPR28058-71] (<a href='/en-us/products/primary-antibodies/atm-phospho-s1987-antibody-epr28058-71-ab315019'>ab315019</a>) at 1/1000 dilution
Lane 1:
Untreated MEF (mouse embryo fibroblast) whole cell lysate (untreated membrane) at 20 µg
Lane 2:
MEF treated with UV-C for 100J/m2, then recovery 4 hours, whole cell lysate (untreated membrane) at 20 µg
Lane 3:
MEF treated with UV-C for 100J/m2, then recovery 4 hours, whole cell lysate (phosphatase treated membrane) at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 349 kDa,124 kDa
false
Exposure time: 81s
Related conjugates and formulations (1)
-
Anti-ATM antibody [EPR20100] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ATM acts as a coordinator in cellular response to DNA damage highly interacting with multiple components of the DNA repair machinery. It forms a complex with proteins like NBS1 and MRN complex facilitating repair by recruiting and activating other proteins involved in homologous recombination and non-homologous end joining pathways. ATM also modulates p53 activity a primary response factor in cellular stress management linking ATM to control of cell cycle arrest and apoptosis. This positions ATM as an integral part of maintaining cellular integrity in face of genomic insult.
Pathways
ATM integrates neatly within the DNA damage response and cell cycle control pathways. ATM's operative relationship with the MRN complex and its role in the PI3K-related protein kinase family helps initiate appropriate repair processes upon DNA damage detection. Additionally ATM regulates the activity of proteins such as Chk2 which further propagates signals to p53 influencing decisions between cell cycle arrest and apoptosis. These interactions link ATM closely to essential processes like DNA repair and cell survival highlighting its role in genomic maintenance.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (14)
Recent publications for all applications. Explore the full list and refine your search
ACS omega 10:36994-37003 PubMed40893218
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 23:795 PubMed40665360
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine (Cambridge, Mass.) 30:205 PubMed39522000
2024
Applications
Unspecified application
Species
Unspecified reactive species
World journal of gastrointestinal oncology 16:1453-1464 PubMed38660649
2024
Applications
Unspecified application
Species
Unspecified reactive species
MedComm 5:e548 PubMed38645664
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:4521 PubMed37607907
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports. Medicine 4:101015 PubMed37075701
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of oncology 2022:9672773 PubMed36276282
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 13:902102 PubMed35865965
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 10:817831 PubMed35309941
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com